| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/03/2003 | US20030126629 Production of a transgenic avian by cytoplasmic injection |
| 07/03/2003 | US20030125657 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 07/03/2003 | US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 07/03/2003 | US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines |
| 07/03/2003 | US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry |
| 07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
| 07/03/2003 | US20030125296 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 07/03/2003 | US20030125258 Bone polypeptide-1 |
| 07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030125230 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation |
| 07/03/2003 | US20030124743 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor |
| 07/03/2003 | US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents |
| 07/03/2003 | US20030124678 Interleukin-2 mutants with reduced toxicity |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124668 Plasmid for use in gene expression, mapping and mutagenesis; transposases |
| 07/03/2003 | US20030124666 Membrane proteins; antiproliferative agents; antitumor agents; antisense agents; neovascularization |
| 07/03/2003 | US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124655 Receptor protein specifically recognizing bacterial dna |
| 07/03/2003 | US20030124649 Membrane associated proteins |
| 07/03/2003 | US20030124648 Vector/plasmid for efficient and accurate transfer of preferential gene to rodent cells; glutamine synthetases |
| 07/03/2003 | US20030124637 Diagnosing organopathy; monoclonal antibodies; antiinflammatory agents |
| 07/03/2003 | US20030124635 Immunoaffinity chromatography; anticaries agents; polyclonal serums |
| 07/03/2003 | US20030124631 Monoclonal antibodies tnhat bind Pseudomona mucoid heteropolysaccharides; mucins; bactericides; cytotoxic agents |
| 07/03/2003 | US20030124629 Methods of detecting a cell |
| 07/03/2003 | US20030124624 Transmembrane proteins produced by hybridomas for distinguishing t-helper cells lines; immunoassays; diagnosing allergies; interleukins |
| 07/03/2003 | US20030124621 Culturing/analyzing reaction of FC receptor-expressing cell line in the presence if immobilized antibody, separate, from Fab fragments; may be pretreated with cytokines or interefrons |
| 07/03/2003 | US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents |
| 07/03/2003 | US20030124614 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124574 Quantifying multiple immunogens; detecting, measuring and monitoring protein, lipids, sugars and metabolite levels; immunogen binding agents (iba) |
| 07/03/2003 | US20030124573 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 07/03/2003 | US20030124558 Monitoring gestation in humans; in vitro fertilization and embryo transfer; progestins; immunohistochemistry |
| 07/03/2003 | US20030124534 Measuring expression of nucleotide sequences in cells |
| 07/03/2003 | US20030124533 HIP1 cancer markers |
| 07/03/2003 | US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124510 Protein whose genome contains a region which is homologous to DNA restriction enzyme present in plasmid of escherichia coli; immunologically reactive; use in diagnostics and vaccines |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124141 Helicobacter polypeptides and corresponding polynucleotide molecules |
| 07/03/2003 | US20030124140 Ovarian tumor polypeptides, polynucleotides that encode them, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells |
| 07/03/2003 | US20030124134 Pharmaceutical compositions and methods to vaccinate against candidiasis |
| 07/03/2003 | US20030124132 Using targeted or non-targeted coagulants to cause tumor vasculature thrombosis. |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124127 Targeting leukemia cells |
| 07/03/2003 | US20030124125 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10 |
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124122 Simultaneous stimulation and concentration of cells |
| 07/03/2003 | US20030124121 Treating septic arthritis |
| 07/03/2003 | US20030124119 Antibody is dissolved in a buffer solution containing as a buffer acetic acid, citric acid, phosphoric acid, and/or salts thereof and is a solution of pH 5 to 8. |
| 07/03/2003 | US20030124117 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124058 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 07/03/2003 | US20030124057 Complex of antibody and radionucleotide; therapy, medical diagnosis |
| 07/03/2003 | US20030124056 Carrier molecules |
| 07/03/2003 | CA2510745A1 Human antibodies against human glycoprotein vi and their use |
| 07/03/2003 | CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | CA2471417A1 Uses of an endothelial cell receptor |
| 07/03/2003 | CA2471140A1 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | CA2471136A1 Mono-and dual chemokine/cytokine constructs |
| 07/03/2003 | CA2471116A1 Method for cloning of variable domain sequences |
| 07/03/2003 | CA2470976A1 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | CA2470844A1 Novel compositions and methods for cancer |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470316A1 Lyophilized preparation containing antibodies to the egf receptor |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469972A1 Bone polypeptide-1 |
| 07/03/2003 | CA2466885A1 Non-human primate fc receptors and methods of use |
| 07/03/2003 | CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/02/2003 | EP1324040A2 Direct selection of cells by secretion product |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323820A2 Process for facillitated recovery of heterologous proteins from bacterial cells |
| 07/02/2003 | EP1323733A1 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 07/02/2003 | EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322768A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 07/02/2003 | EP1322763A2 Listeria inocua , genome and applications |
| 07/02/2003 | EP1322761A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322749A1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 07/02/2003 | EP1322669A1 Stabilisation of immunoglobulins at a low ph |
| 07/02/2003 | EP1322666A2 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents |
| 07/02/2003 | EP1322665A2 Hiv peptidesform concerved regions in gag p17 and 924 and their application in e.g vacines |
| 07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |